Abstract:Background: The SOX4 transcription factor is involved in the development and cell fate decision. Although upregulation of SOX4 has been described in human prostate cancer (PCa), the prognostic value of SOX4 and its exact role in PCa progression remain unclear. Methods: Three tissue microarrays were constructed from 241 Chinese PCa patients who underwent TURP. Immunohistochemistry (IHC) was used to detect the expression of SOX4. Genetic aberrations of epidermal growth factor receptor and HER2 were detected by fluorescence in situ hybridization. The effect of SOX4 on proliferation was evaluated by MTT (methyl thiazolyl tetrazelium), and cell migration and invasion were evaluated by transwell and wound-healing assays. The distribution of cell-cycle phase was analyzed by flow cytometry. Real-time PCR and western blot were used to study transcript and protein levels. Results: Using tissue microarray, we found that SOX4 was overexpressed in 33.0% (76/230) Chinese PCa patients by IHC. SOX4 overexpression was significantly associated with high Gleason scores ( P =0.009) and the presence of distant metastasis ( P =0.023). Additionally, SOX4 overexpression was significantly correlated with high Ki67 labeling index ( P =0.005) and tended to associate with amplification of HER2 ( P =0.052) in our cohort. Notably, SOX4 was correlated with cancer-specific mortality of PCa patients by Kaplan–Meier analysis ( P =0.001). Multivariate Cox regression analysis indicated that SOX4 was an unfavorable independent prognostic factor in Chinese PCas ( P =0.017). SOX4 overexpression enhanced proliferation of Vcap cells and siRNA knockdown of SOX4 significantly decreased Vcap cell migration and invasion, suggesting a role of SOX4 in cancer metastasis. Additionally, flow cytometry DNA analysis revealed that siRNA SOX4 leads to significant accumulation of cells in the S phase and marked decrease of cells in the G2/M phase. Further in vitro study revealed that SOX4 silencing could inhibit TGF-β (transforming growth factor-β)-induced epithelial–mesenchymal transition (EMT) in Vcap cells. Overexpression of SOX4 could promote the EMT phenotype in Vcap cells. Conclusions: Our results define an important role for SOX4 in the progression of PCa by orchestrating EMT and may serve as a prognostic marker for PCa patients.

Over-expression of Sox4 and Β-Catenin is Associated with a Less Favorable Prognosis of Osteosarcoma

Aberrant CXCR4 and Β-Catenin Expression in Osteosarcoma Correlates with Patient Survival.

The prognostic significance of CD44V6, CDH11, and β-catenin expression in patients with osteosarcoma.

Association Between Expression of Nuclear Receptor Co-Activator 5 Protein and Prognosis in Postoperative Patients with Osteosarcoma

DownRegulated SOX4 Expression Suppresses Cell Proliferation, Migration, and Induces Apoptosis in Osteosarcoma In Vitro and In Vivo

Expression of Chemokine CXCL14 in Primary Osteosarcoma and Its Association with Prognosis

Association of SOX4 Regulated by Tumor Suppressor Mir-30A with Poor Prognosis in Low-Grade Chondrosarcoma

Clinicopathological Significance Of Sox4, Beta-Catenin, And Tcf4 Expression In Esophageal Squamous Cell Carcinoma

The clinical value of CXCR4, HER2 and CD44 in human osteosarcoma: A pilot study.

Clinicopathological And Prognostic Significance Of Beta-Catenin Expression In Patients With Bone And Soft Tissue Sarcoma: A Meta-Analysis

Long Non-Coding RNA Sox4 Promotes Proliferation and Migration by Activating Wnt/β-catenin Signaling Pathway in Osteosarcoma.

Expression of CXCR4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma

SOX4 is Overexpressed in Diffusely Infiltrating Astrocytoma and Confers Poor Prognosis.

Over-expression of HER 2 promotes cell metastasis and is associated with the prognosis of osteosarcoma

Clinicopathological and prognostic values of ErbB receptor family amplification in primary osteosarcoma.

Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma

SOX4 is Associated with Poor Prognosis in Prostate Cancer and Promotes Epithelial–mesenchymal Transition in Vitro

High Expression of Integrin-Binding Sialoprotein (IBSP) is Associated with Poor Prognosis of Osteosarcoma.

The expression of novel gene URG4 in osteosarcoma: correlation with patients' prognosis.

Expression of apoptosis related gene Bcl 2 and Bax in osteosarcoma and their relationship with the prognosis

Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.